| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.979 | 0 | 0 | - | 0 | 0 | 900 | 9.137 | 16.244 | 1.278.276 |
| Total Income - EUR | 5.979 | 0 | 0 | - | 0 | 0 | 1.092 | 9.303 | 16.770 | 1.278.276 |
| Total Expenses - EUR | 4.541 | 11 | 0 | - | 0 | 74 | 8.472 | 10.121 | 7.793 | 1.231.987 |
| Gross Profit/Loss - EUR | 1.438 | -11 | 0 | - | 0 | -74 | -7.381 | -817 | 8.976 | 46.289 |
| Net Profit/Loss - EUR | 1.258 | -11 | 0 | - | 0 | -74 | -7.408 | -1.092 | 7.451 | 38.706 |
| Employees | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Omega Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 80 | 79 | 78 | - | 75 | 0 | 669 | 383 | 96 | 26.763 |
| Current Assets | 3.878 | 3.827 | 3.762 | - | 3.622 | 3.553 | 3.373 | 1.767 | 2.324 | 1.495.392 |
| Inventories | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | - | 0 | 0 | 7 | 0 | 0 | 1.490.606 |
| Cash | 3.878 | 3.827 | 3.762 | - | 3.622 | 3.553 | 3.366 | 1.767 | 2.324 | 4.786 |
| Shareholders Funds | 3.634 | 3.586 | 3.525 | - | 3.394 | 3.255 | -4.225 | -5.330 | 2.137 | 38.754 |
| Social Capital | 45 | 3.588 | 44 | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 324 | 321 | 315 | - | 303 | 298 | 7.597 | 6.953 | 283 | 1.484.418 |
| Income in Advance | 0 | 0 | 0 | - | 0 | 0 | 669 | 527 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Omega Medical S.r.l.